Risk factors for community-acquired pneumonia in adults: a population-based case-control study

Although community-acquired pneumonia (CAP) remains a major cause of hospitalization and death, few studies on risk factors have been performed. A population-based case-control study of risk factors for CAP was carried out in a mixed residential-industrial urban area of 74,610 adult inhabitants in the Maresme (Barcelona, Spain) between 1993 and 1995. All patients living in the area and clinically suspected of having CAP at primary care facilities and hospitals were registered. In total, 205 patients with symptoms, signs and radiographic infiltrate compatible with acute CAP participated in the study. They were matched by municipality, sex and age with 475 controls randomly selected from the municipal census. Risk factors relating the subject's characteristics and habits, housing conditions, medical history and treatments were investigated by means of a questionnaire. In the univariate analysis, an increased risk of CAP was associated with low body mass index, smoking, respiratory infection, previous pneumonia, chronic lung disease, lung tuberculosis, asthma, treated diabetes, chronic liver disease, and treatments with aminophiline, aerosols and plastic pear-spacers. In multivariate models, the only statistically significant risk factors were current smoking of >20 cigarettes x day(-1) (odds ratio (OR)=2.77; 95% confidence interval (CI) 1.14-6.70 compared with never-smokers), previous respiratory infection (OR=2.73; 95% CI 1.75-4.26), and chronic bronchitis (OR=2.22; 95% CI 1.13-4.37). Benzodiazepines were found to be protective in univariate and multivariate analysis (OR=0.46; 95% CI 0.23-0.94). This population-based study provides new and better established evidence on the factors associated with the occurrence of pneumonia in the adult community.

This article has been cited by other articles:

				S. Singh, A. V. Amin, and Y. K. Loke Long-term Use of Inhaled Corticosteroids and the Risk of Pneumonia in Chronic Obstructive Pulmonary Disease: A Meta-analysis Arch Intern Med, February 9, 2009; 169(3): 219 - 229. [Abstract] [Full Text] [PDF]

				A Sliedrecht, W P J den Elzen, T J M Verheij, R G J Westendorp, and J Gussekloo Incidence and predictive factors of lower respiratory tract infections among the very elderly in the general population. The Leiden 85-plus Study Thorax, September 1, 2008; 63(9): 817 - 822. [Abstract] [Full Text] [PDF]

				T. Benfield, P. Lange, and J. Vestbo COPD Stage and Risk of Hospitalization for Infectious Disease Chest, July 1, 2008; 134(1): 46 - 53. [Abstract] [Full Text] [PDF]

				J. Almirall, I. Bolibar, M. Serra-Prat, J. Roig, I. Hospital, E. Carandell, M. Agusti, P. Ayuso, A. Estela, A. Torres, et al. New evidence of risk factors for community-acquired pneumonia: a population-based study Eur. Respir. J., June 1, 2008; 31(6): 1274 - 1284. [Abstract] [Full Text] [PDF]

				D. Kerman and J. S. Barkin Acid Suppression Not the Only Culprit of Community-Acquired Pneumonia Arch Intern Med, May 26, 2008; 168(10): 1118 - 1119. [Full Text] [PDF]

				L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe Complex chronic comorbidities of COPD Eur. Respir. J., January 1, 2008; 31(1): 204 - 212. [Abstract] [Full Text] [PDF]

				M. Woodhead Inhaled Corticosteroids Cause Pneumonia ...or Do They? Am. J. Respir. Crit. Care Med., July 15, 2007; 176(2): 111 - 112. [Full Text] [PDF]

				P. Ernst, A. V. Gonzalez, P. Brassard, and S. Suissa Inhaled Corticosteroid Use in Chronic Obstructive Pulmonary Disease and the Risk of Hospitalization for Pneumonia Am. J. Respir. Crit. Care Med., July 15, 2007; 176(2): 162 - 166. [Abstract] [Full Text] [PDF]

				E M W van de Garde, E Hak, P C Souverein, A W Hoes, J M M van den Bosch, and H G M Leufkens Statin treatment and reduced risk of pneumonia in patients with diabetes Thorax, November 1, 2006; 61(11): 957 - 961. [Abstract] [Full Text] [PDF]

				M. I. Restrepo, E. M. Mortensen, J. A. Pugh, and A. Anzueto COPD is associated with increased mortality in patients with community-acquired pneumonia Eur. Respir. J., August 1, 2006; 28(2): 346 - 351. [Abstract] [Full Text] [PDF]

				E. M. W. van de Garde, P. C. Souverein, J. M. M. van den Bosch, V. H. M. Deneer, and H. G. M. Leufkens Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population Eur. Respir. J., June 1, 2006; 27(6): 1217 - 1222. [Abstract] [Full Text] [PDF]

				J. Rello, A. Rodriguez, A. Torres, J. Roig, J. Sole-Violan, J. Garnacho-Montero, M. V. de la Torre, J. M. Sirvent, M. Bodi, and for the CAPUCI study investigators Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia Eur. Respir. J., June 1, 2006; 27(6): 1210 - 1216. [Abstract] [Full Text] [PDF]

				A. de Roux, S. Ewig, E. Garcia, M. A. Marcos, J. Mensa, H. Lode, and A. Torres Mixed community-acquired pneumonia in hospitalised patients. Eur. Respir. J., April 1, 2006; 27(4): 795 - 800. [Abstract] [Full Text] [PDF]

				G. W. Waterer, L. A. Kessler, and R. G. Wunderink Medium-Term Survival after Hospitalization with Community-Acquired Pneumonia Am. J. Respir. Crit. Care Med., April 15, 2004; 169(8): 910 - 914. [Abstract] [Full Text] [PDF]

				M. Bartolome, J. Almirall, J. Morera, G. Pera, V. Ortun, J. Bassa, I. Bolibar, X. Balanzo, A. Verdaguer, and the Maresme Community-Acquired Pneumonia Study Gro A population-based study of the costs of care for community-acquired pneumonia Eur. Respir. J., April 1, 2004; 23(4): 610 - 616. [Abstract] [Full Text] [PDF]

				J. Almirall, I. Bolibar, P. Toran, G. Pera, X. Boquet, X. Balanzo, and G. Sauca Contribution of C-Reactive Protein to the Diagnosis and Assessment of Severity of Community-Acquired Pneumonia Chest, April 1, 2004; 125(4): 1335 - 1342. [Abstract] [Full Text] [PDF]

				A. de Roux, M. A. Marcos, E. Garcia, J. Mensa, S. Ewig, H. Lode, and A. Torres Viral Community-Acquired Pneumonia in Nonimmunocompromised Adults Chest, April 1, 2004; 125(4): 1343 - 1351. [Abstract] [Full Text] [PDF]

				H. Hemila, J. Virtamo, D. Albanes, and J. Kaprio Vitamin E and Beta-Carotene Supplementation and Hospital-Treated Pneumonia Incidence in Male Smokers Chest, February 1, 2004; 125(2): 557 - 565. [Abstract] [Full Text] [PDF]

				H. Friedman, C. Newton, and T. W. Klein Microbial Infections, Immunomodulation, and Drugs of Abuse Clin. Microbiol. Rev., April 1, 2003; 16(2): 209 - 219. [Abstract] [Full Text] [PDF]

				W S Lim, J T Macfarlane, and C L Colthorpe Respiratory diseases in pregnancy {bullet} 2: Pneumonia and pregnancy Thorax, May 1, 2001; 56(5): 398 - 405. [Full Text]

				I. Baik, G. C. Curhan, E. B. Rimm, A. Bendich, W. C. Willett, and W. W. Fawzi A Prospective Study of Age and Lifestyle Factors in Relation to Community-Acquired Pneumonia in US Men and Women Arch Intern Med, November 13, 2000; 160(20): 3082 - 3088. [Abstract] [Full Text] [PDF]

				M. Moretti, C. Cilione, A. Tampieri, C. Fracchia, A. Marchioni, and S. Nava Incidence and causes of non-invasive mechanical ventilation failure after initial success Thorax, October 1, 2000; 55(10): 819 - 825. [Abstract] [Full Text]

				J. Almirall, C. A. Gonzalez, X. Balanzo, and I. Bolibar Proportion of Community-Acquired Pneumonia Cases Attributable to Tobacco Smoking Chest, August 1, 1999; 116(2): 375 - 379. [Abstract] [Full Text] [PDF]